Galderma Group Ag (GDERF) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Warm welcome to the Golderma full year 24 financial results call. As customary, the press release along with the Golderma's 24 finance reports were published at 7 a.m. Central European Standard Time today and can be consulted on our corporate website at any time. Today's presentation slides as well as the recording of the webcast will be made available on our website after the call. Please be advised that today's presentation contains forward-looking statements, which would be treated with appropriate level of caution as detailed on this slide. Let me now introduce today's full year financial results webcast. Dr. Flemming Ornskov, CEO of GoDerma, will provide a performance update for the full year, including commercial and innovation highlights by product category. Thomas Dietrich, CFO, will then introduce the 24 financial results and the financial outlook. Both Flemming and Thomas will be available to answer questions from financial analysts before Flemming provides his final remarks to close the webcast. With this, I would like to invite Flemming to start Galderma's highlight for 24. Flemming, over to you. Thank you, Emil. Good morning, good afternoon, and welcome to Galderma's 2024 financial results webcast. Today, we're excited to share our record-breaking performance as we close our first year as a publicly traded company with strong progress across our product categories and future growth platforms. DELDRMA is on a strong growth trajectory for 2025 and beyond as we focus on the continued execution of our growth-focused integrated dermatology strategy. Starting with our financial results highlights, Golderma delivered a record $4.4 billion in net sales for 2024, achieving 9.3% year-on-year growth at constant currency. Performance was widespread across product ca...